Email This Article

Headlines & Perspectives
Lilly's Sepsis Drug Draws FDA Scrutiny
By Samantha Shaddock
02/04/09 - 04:11 PM EST
The FDA has said a study of Xigris shows an increased incidence of bleeding in some patients.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,409.91 1,103.71 2,195.56 34.70
Oil *
71.56
UP
72.86
UP
7.77
UP
11.83
UP
0.47
10 Yr
3.47%
SPDR Gold
110.32
+0.70%
+0.71%
+0.54%
+1.37%
Data delayed 20 minutes

Brokerage Partners